BioMérieux EPISEQ SARS-COV-2 Software
BioMérieux has launched EPISEQ SARS-COV-2, a sequencing- and cloud-based software solution to support microbiology labs in identification and reporting from raw sequencing data related to SARS-CoV-2 variants.
The SARS-CoV-2 EPISEQ application is intended to identify SARS-CoV-2 variants using samples from positive patients. The platform is automatically updated weekly and identifies variants based on international nomenclatures including new variants of concern as defined by the World Health Organization and the US Centers for Disease Control and Prevention. The EPISEQ SARS-COV-2 software is compatible with llumina, Oxford Nanopore, and Thermo Fisher Scientific sequencing platforms and is intended to be easy to use for microbiology labs without bioinformatics knowledge or computing resources. The application also permits the export of viral genome assemblies and mutations in order to facilitate reporting to national public health authorities and for epidemiology studies.
EPISEQ SARS-COV-2 is the third application hosted on the EPISEQ platform, along with EPISEQ CS for bacterial hospital acquired infections and EPISEQ 16S for microbiome analysis.